WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

Bloomberg <https://www.bloomberg.corn/news/articles/2021-05-05/moderna-booster-shot-bolsters-antibodies- against-variant-strains?srnd—premium> (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid- stage vaccine trial, and it found that its COVID booster shots "gave positive

. Bloomberg <https://www.bloomberg.com/news/articles/2020-09-22/pfizer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

ness. Bloomberg <https://www.bloomberg.com/news/articles/2020-11-11/spotlight-to-shift-to-modema-s-covid- vaccine-trial-in-days?smd=premium> (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 EFTA00137117 cases that helped Pfizer Inc. get results for its vaccine trial earlier this

f it's approved." Bloomberg <https://www.bloomberg.com/news/articles/2020-11-30/modema-plans-to-seek-u-s-eu-clearance-for- covid-19-vaccine> (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Modena shot in August," while the EU, Canada, and

believes in science, not conspiracy theories." FDA Outlines Fast Path For New Vaccines, Booster Shots To Cover New Virus Variants. Bloomberg (2/22, Langreth, Cortez, 3.57M) reports, "Drugmakers won't have to perform massive trials for new vaccines or booster shots developed to combat worrisome new varian

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and

rian Jack tested positive over the weekend, according to a source. Moderna's Vaccine Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive

lity of protection is. We're following it very closely." Modern Joins Pfizer In Exporting US-Manufactured Vaccine Doses. Bloomberg (5/20, Wingrove, Langreth, 3.57M) reports that Moderna "has begun exporting U.S.-produced Covid-19 vaccines to other countries, a key step as U.S. vaccine supply begins to be

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

rian Jack tested positive over the weekend, according to a source. Moderna's Vaccine Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping